SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000912057-02-024218
Filing Date
2002-06-14
Accepted
2002-06-14 09:50:12
Documents
11
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F a2080893z20-f.txt 20-F 415316
3 EXHIBIT 10.27 a2080893zex-10_27.txt EX-10.27 74471
4 EXHIBIT 10.28 a2080893zex-10_28.txt EX-10.28 51811
5 EXHIBIT 10.29 a2080893zex-10_29.txt EX-10.29 63071
6 EXHIBIT 10.30 a2080893zex-10_30.txt EX-10.30 68624
7 EXHIBIT 10.31 a2080893zex-10_31.txt EX-10.31 30785
8 EXHIBIT 10.32 a2080893zex-10_32.txt EX-10.32 30749
9 EXHIBIT 10.33 a2080893zex-10_33.txt EX-10.33 33911
10 EXHIBIT 10.34 a2080893zex-10_34.txt EX-10.34 56734
11 EXHIBIT 10.35 a2080893zex-10_35.txt EX-10.35 49114
12 EXHIBIT 10.36 a2080893zex-10_36.txt EX-10.36 151713
  Complete submission text file 0000912057-02-024218.txt   1029020
Mailing Address 700 BAY ST STE 1000 TORONTO ONTARIO CANADA M5G 1Z6
Business Address 700 BAY ST SUITE 1000 TORONTO ONTARIO CANA A6 00000 2127025700
VISIBLE GENETICS INC (Filer) CIK: 0001010819 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-28550 | Film No.: 02678795
SIC: 2835 In Vitro & In Vivo Diagnostic Substances